Nephrotoxicity/renal failure after therapy with 90Yttrium- and 177Lutetium-radiolabeled somatostatin analogs in different types of neuroendocrine tumors: a systematic review
Sign Up to like & getrecommendations! Published in 2020 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001198
Abstract: Background/objective Data regarding the nephrotoxicity of the peptide receptor radionuclide therapy (PRRT) with 90Yttrium- and 177Lutetium-radiolabeled somatostatin analogs (RSA) are inconclusive. We aimed to evaluate the short- and long-term nephrotoxicity following PRRT usage in patients… read more here.
Keywords: therapy; radiolabeled somatostatin; nephrotoxicity; somatostatin analogs ... See more keywords